PhytoHealth (TPE:4108) Cyclically Adjusted PB Ratio: (As of Sep. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:4108 PhytoHealth Corp TPE:4108
70 GF Score
Price NT$11.30
GF Value NT$14.56
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is PhytoHealth Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


PhytoHealth  (TPE:4108) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


PhytoHealth Cyclically Adjusted PB Ratio Related Terms


PhytoHealth Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for PhytoHealth's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PhytoHealth Cyclically Adjusted PB Ratio Chart

PhytoHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.56 1.28 1.51 1.19 0.98

PhytoHealth Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.96 1.06 0.96 0.89 0.86

TPE:4108 vs ZTS: Cyclically Adjusted PB Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, PhytoHealth's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PhytoHealth Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PhytoHealth's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where PhytoHealth's Cyclically Adjusted PB Ratio falls into.


TPE:4108
70GF Score
PhytoHealth Corp TPE:4108
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PhytoHealth Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

PhytoHealth's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, PhytoHealth's adjusted Book Value per Share data for the three months ended in Jun. 2026 was:

Adj_Book=Book Value per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=11.849/333.9520*333.9520
=11.849

Current CPI (Jun. 2026) = 333.9520.

PhytoHealth Quarterly Data

Book Value per Share CPI Adj_Book
201609 14.043 241.428 19.425
201612 13.725 241.432 18.985
201703 13.459 243.801 18.436
201706 13.205 244.955 18.003
201709 12.880 246.819 17.427
201712 12.315 246.524 16.682
201803 12.675 249.554 16.962
201806 12.313 251.989 16.318
201809 12.001 252.439 15.876
201812 11.528 251.233 15.324
201903 11.388 254.202 14.961
201906 11.182 256.143 14.579
201909 10.890 256.759 14.164
201912 10.384 256.974 13.495
202003 9.814 258.115 12.697
202006 10.193 257.797 13.204
202009 10.149 260.280 13.022
202012 10.089 260.474 12.935
202103 12.115 264.877 15.274
202106 12.165 271.696 14.952
202109 12.155 274.310 14.798
202112 12.026 278.802 14.405
202203 11.910 287.504 13.834
202206 11.567 296.311 13.036
202209 11.601 296.808 13.053
202212 11.466 296.797 12.901
202303 11.424 301.836 12.640
202306 11.622 305.109 12.721
202309 11.419 307.789 12.390
202312 11.432 306.746 12.446
202403 11.627 312.332 12.432
202406 11.456 314.175 12.177
202409 12.073 315.301 12.787
202412 11.950 315.605 12.645
202503 11.737 319.799 12.256
202506 11.485 322.561 11.891
202509 11.450 324.800 11.773
202512 11.573 324.054 11.926
202603 11.288 330.213 11.416
202606 11.849 333.952 11.849

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is PhytoHealth (TPE:4108) Overvalued in 2026?

Based on GuruFocus' analysis, PhytoHealth stock appears to be undervalued. The current stock price of NT$11.30 is trading 22.4% below its estimated GF Value™ of NT$14.56. GuruFocus considers PhytoHealth to be Modestly Undervalued.

Key valuation signals for TPE:4108:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: NT$14.56 vs. price of NT$11.30 (22.4% below fair value)
  • GF Score™: 70/100 with 3 warning signs

No single metric tells the full story. See the TPE:4108 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PhytoHealth Business Description

Address Fuxing North Road, No. 167, 5th Floor - 1, Zhongshan District, Taipei, TWN, 104
PhytoHealth Corp engages in the research and development, production, manufacture, and sale of pharmaceutical drugs, cosmetics, Class B drugs, and dietary supplements. The company's product portfolio comprises White Blood Crystals Injection, White Pain Relief Soft Capsules, WhiteGilead, and White AminoSpeed supplements. Additionally, it is developing PHN031 (White Bone) for the prevention of osteoporosis; PHN033 (White Sugar) for the treatment of diabetic nephropathy; PHN016 for cancer treatment; and PHN017 for the treatment of cytokine storm. The company's reportable operating segments are: Pharmaceutical drugs and dietary supplement, which generate maximum revenue, Medical diagnostic products, and Precision medical equipment. Geographically, it derives maximum revenue from Taiwan.
70GF Score

Get the complete analysis for TPE:4108

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$11.30
Price
NT$14.56
GF Value